926922-40-9 Usage
Uses
Used in Pharmaceutical Research:
4-Bromo-5-methyl-1H-Indazole is used as a research compound for its potential to contribute to the development of new pharmaceuticals. Its unique structure allows it to be a candidate for drug discovery, particularly in the areas of medicinal chemistry and drug design.
Used in Chemical Synthesis:
In the chemical synthesis industry, 4-Bromo-5-methyl-1H-Indazole is used as a building block for the creation of other chemical compounds. Its distinct functional groups and structural features make it a valuable intermediate in the synthesis of various organic and pharmaceutical compounds.
Used in Medicinal Chemistry:
4-Bromo-5-methyl-1H-Indazole is utilized as a starting material in medicinal chemistry for the design and synthesis of novel therapeutic agents. Its bromine and methyl substituents may confer specific biological activities, making it a promising scaffold for the development of drugs targeting various diseases.
While the provided materials do not specify particular industries or applications beyond pharmaceutical research and chemical synthesis, the potential uses listed above are based on the compound's properties and typical applications of similar compounds in the field. Further research and development could reveal additional uses in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 926922-40-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,6,9,2 and 2 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 926922-40:
(8*9)+(7*2)+(6*6)+(5*9)+(4*2)+(3*2)+(2*4)+(1*0)=189
189 % 10 = 9
So 926922-40-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H7BrN2/c1-5-2-3-7-6(8(5)9)4-10-11-7/h2-4H,1H3,(H,10,11)
926922-40-9Relevant articles and documents
Preparation method of 4-bromo-5-methyl-1H-indazole
-
Paragraph 0007; 0022; 0028-0032; 0038-0040; 0046-0047, (2021/02/06)
The invention discloses a preparation method of 4-bromo-5-methyl-1H-indazole, wherein the preparation method comprises the specific steps: (1) reacting a compound (II) in the presence of lithium diisopropylamide to generate a lithium reagent, and reacting
Novel N9-arenethenyl purines as potent dual Src/Abl tyrosine kinase inhibitors
Wang, Yihan,Shakespeare, William C.,Huang, Wei-Sheng,Sundaramoorthi, Raji,Lentini, Scott,Das, Sasmita,Liu, Shuangying,Banda, Geeta,Wen, David,Zhu, Xiaotian,Xu, Qihong,Keats, Jeffrey,Wang, Frank,Wardwell, Scott,Ning, Yaoyu,Snodgrass, Joseph T.,Broudy, Mark I.,Russian, Karin,Dalgarno, David,Clackson, Tim,Sawyer, Tomi K.
scheme or table, p. 4907 - 4912 (2009/05/30)
Novel N9-arenethenyl purines, optimized potent dual Src/Abl tyrosine kinase inhibitors, are described. The key structural feature is a trans vinyl linkage at N9 on the purine core which projects hydrophobic substituents into the sele
UNSATURATED HETEROCYCLIC DERIVATIVES
-
Page/Page column 42-43, (2008/06/13)
This invention relates to compounds of the general formula: in which the variable groups are as defined herein, and to their preparation and use.
